14th International Symposium on Thrombolysis, Thrombectomy and Acute Stroke Therapy: Proceedings and summary of discussions

Sheth, Sunil A; Lopez‐Rivera, Victor; Lee, Songmi; Savitz, Sean I; Liebeskind, David S; Grotta, James C.

doi:10.1177/1747493019838760

Cited by 7 publications

(2 citation statements)

References 101 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In any case, time remains fundamental with regard to the results that can be obtained 14 . In the present study, acute-phase therapeutic interventions were performed on 32.44% of the stroke patients treated at HEC, which is a high rate even by international standards 25 , 26 . Nevertheless, this demonstrates that there is a need to expand VT and MT care, considering the efficiency of these therapies not only for reducing mortality but also for reducing the disabilities acquired by patients 27 .…”

Section: Discussionmentioning

confidence: 99%

Epidemiological analysis of stroke patients with emphasis on access to acute-phase therapies

ROSÁRIO

NETO

PESSOTTI

et al. 2022

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

Background: Stroke is a public health problem. For patients with ischemic stroke, venous thrombolysis and mechanical thrombectomy are effective therapeutic options. However, even after the National Stroke Treatment Guidelines were published in 2012, the number of cases treated is still lower than expected. Objective: To identify the determining factors for obtaining access to acute-phase therapies in the state of Espírito Santo (ES) and investigate the profile of stroke patients treated at the Central State Hospital (HEC). Methods: Retrospective data from the medical records of 1078 patients from May 2018 to December 2019 were analyzed. Results: Among the 1,078 patients, 54.9% were men and the most prevalent age group was 60 to 79 years. Systemic arterial hypertension was the main single risk factor. Regarding treatment modality among the patients who arrived at the HEC within the therapeutic window, 47% received some type of acute-phase therapy. Waking up with the deficit was the main contraindication for venous thrombolysis in these cases. Conclusions: Application of the flowchart established by SESA-ES seemed to be effective for enabling responsiveness of care for stroke victims. Public emergency transport services had a fundamental role in this process. In addition, the care provided by the tertiary stroke center provided excellent access to acute-phase therapies. However, despite the efficiency of the service provided at the HEC, it only reached a maximum of 50% of the ES population. This service model therefore needs to be expanded throughout the state.

show abstract

Section: Discussionmentioning

confidence: 99%

Epidemiological analysis of stroke patients with emphasis on access to acute-phase therapies

ROSÁRIO

NETO

PESSOTTI

et al. 2022

Arq. Neuro-Psiquiatr.

View full text Add to dashboard Cite

show abstract

“…The use of intravenous thrombolysis (IVT) and mechanical thrombectomies (MTs) in acute stroke patients varied greatly within Asia. Earlier studies showed greater use in East Asia compared to other Asian regions [ 37 ]. In Asia, most countries adopted the dosage of 0.9 mg/kg while in Japan, Pakistan, Vietnam, and in some hospitals in the Philippines and India 0.6 mg/kg was the standard dose [ 38 ].…”

Section: Treatment Approaches and Infrastructure For Hyperacute Strok...mentioning

confidence: 99%

Stroke in Asia

Tan,

Pandian,

Liu

et al. 2024

Cerebrovasc Dis Extra

View full text Add to dashboard Cite

Background There is a significant burden of stroke in Asia. Asia has the largest population in the world in 2023, estimated at 4.7 billion. Approximately 9.5-10.6 million strokes will be anticipated annually in the backdrop of a diverse group of well-developed and less developed countries with large disparities in stroke care resources. In addition, Asian countries are in varying phases of epidemiological transition. Summary In this review, we examined recent epidemiological features of ischaemic stroke and intracerebral haemorrhage in Asia with recent developments in hyperacute stroke reperfusion therapy and technical improvements in intracerebral haemorrhage. The article also discussed the spectrum of cerebrovascular diseases in Asia which include intracranial atherosclerosis, intracerebral haemorrhage, infective aetiologies of stroke, moyamoya disease, vascular dissection, radiation vasculopathy and cerebral venous thrombosis. Key Messages The review of selected literature and recent updates, call for attention to the different requirements for resources within Asia and highlights the breadth of cerebrovascular diseases still requiring further research and more effective therapies,

show abstract